Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longterm Efficacy and Safety of NVP-based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.

NCT00736502 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00736502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longterm Efficacy and Safety of NVP-based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
Not reported
Enrollment
280 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections